Use of SSRIs With Oral Anticoagulants and Risk of Major Bleeding
April 12, 2024
A recent population-based, nested case-control study assessed wheth...
Read More
FDA Clears First Prescription Digital Therapeutic Authorized for Treatment of MDD
April 1, 2024
The FDA has cleared the first prescription digital therapeutic auth...
Read More
Pharmacological Treatments for Psychotic Depression
March 22, 2024
Current treatment guidelines for psychotic depression recommend a c...
Read More
CDC Issues New Guidance on Identifying, Responding to Suicide Clusters
March 19, 2024
Responding to suicide clusters requires a comprehensive and proacti...
Read More
High Sugar Intake Tied to Increased Risk for Depression
March 11, 2024
A new cross-sectional study examined the association between dietar...
Read More
GLP-1 and Risk of Suicidal Ideation
January 30, 2024
A study investigated concerns regarding reports of suicidal ideatio...
Read More
Optimizing Treatment For Older Adults With Depression
January 4, 2024
Depression in older adults presents distinct difficulties due to it...
Read More
Comparison of Ketamine as Augmentation Treatment for Depression
December 19, 2023
Intravenous racemic ketamine may be a better augmentative treatment...
Read More
STAR-D For Adolescents?
December 8, 2023
Major depressive disorder (MDD) among adolescents carries high morb...
Read More
Use of LSD On The Rise Among Adults With Depression
October 27, 2023
Recently, there's been a resurgence in LSD research for mental heal...
Read More
National Depression Screening Day
October 5, 2023
Like screenings for other illnesses, depression screenings should b...
Read More
FDA Approves Gepirone ER for Treatment of Major Depressive Disorder
September 28, 2023
The U.S. Food and Drug Administration has approved the resubmiss...
Read More